A full-length cDNA copy of clover yellow mosaic virus (CYMV) RNA was constructed from two smaller cDNA clones. In vitro transcription of linearized plasmid with T7 RNA polymerase produced genomic-sized RNA. These transcripts caused symptoms typical of CYMV infection when used to inoculate both a systemic host (Viciafaba) and a local lesion host (Gomphrena globosa).
Electron microscopy of extracts from individual local lesions revealed virus particles identical to native CYMV. Increasing the length of the poly(A) tail from 23 residues to 80 or to 135 residues increased the infectivity rate from 12 % to 17 % or to 35 % that of native CYMV RNA, respectively.
Clover yellow mosaic virus (CYMV) belongs to the potexvirus group of plant viruses. Its genome consists of a linear positive-sense ssRNA which is capped and polyadenylated (AbouHaidar, 1983) . This genomic RNA has been sequenced and was shown to be about 7 kilobases in size with five major open reading frames (ORFs) in the positive sense (Sit et al., 1990) . In order to study the importance of these ORFs as well as non-coding regions with respect to certain biological functions of RNA viruses, in vitro infectious transcripts can be prepared from a complete cDNA clone. This has been achieved with several RNA viruses, including the potexviruses potato virus X (PVX) (Hemenway et al., 1990) , white clover mosaic virus (WC1MV) (Beck et al., 1990) and papaya mosaic virus (PMV) (Sit & AbouHaidar, 1993) . This paper describes the production of infectious in vitro RNA transcripts for the potexvirus CYMV.
CYMV was purified from broad beans (Vicia faba) according to the method of Bancroft et al. (1979) . Viral genomic RNA was extracted from purified virus as described by AbouHaidar (1988) . Synthesis of cDNA was carried out using a modification of the method of Schmid et al. (1987) . The 3' primer ( Fig. 1) which contains an oligo(dT)l 8 fused to an XhoI site was used for first-strand synthesis with avian myeloblastosis virus reverse transcriptase XL (Life Sciences). Second-strand synthesis was primed with the 5' primer ( Fig. 1 ) which contains the bacteriophage T7 promoter fused to the first 18 nucleotides of the 5' end of the viral RNA. Synthesis of the second-strand cDNA was then carried out with Sequenase Version 2.0 (United States Biochemical Corporation). Double-stranded cDNA was adapted with dC tails and annealed to Pstl-digested pUCI8 tailed with dG. White colonies were grown overnight in 2 ml of Terrific Broth (Tartof & Hobbs, 1987) containing 100 gg/ml ampicillin and lysed as described by Birnboim & Doly (1979) . The resulting plasmid DNA was characterized by restriction analysis. No full-length cDNA clones were obtained, probably because of nonspecific primer annealing. However, clone 13 was almost full-length, lacking only 300 nucleotides from the Y terminus. This missing region was inserted into clone 13 from either of two clones, 10D or 94B, which spanned approximately 5"9 kbp and approximately 4.5 kbp of the 3' region of the genome, respectively (Fig. 2 a) . A 2.5 kbp HindIII fragment was released from clone 13 following cleavage at a unique viral HindIII site and the HindIII site of the pUC 18 multiple cloning site. This was replaced by a 2.8 kbp HindIII fragment of either clone 10D or 94B, giving rise to full-length clones 10D37 or 94B18, respectively.
The integrity of the 5'-and Y-terminal 100 nucleotides of these full-length clones was verified by direct sequencing of plasmid DNA using the dideoxynucleotide method (Sanger et al., 1977) with CYMV-specific primers. Clone 10D37 contained a poly(A) tail with 23 A residues, and that of 94B 18 was shown to contain only 18 A residues. Two nucleotide changes were found within the coat protein-coding region of these and several other CYMV cDNA clones as compared to the published sequence of the 3' region of CYMV (AbouHaidar & Lai, 1989) . The first is a deletion of a G residue in position 6854 and the second is an additional C residue following the C found in position 6871. This changes the amino acid sequence from... P Y H R P E * to... L I T G P E * where * represents the termination codon. The latter amino acid sequence is similar to that found by White et al. (1991) in the non-structural protein-coat protein fusion product encoded by the defective interfering RNA found associated with the genomic CYMV R N A . The former is probably the result of a sequencing artefact. Full-length clones 10D37 and 94B18 were linearized with XhoI prior to in vitro transcription with T7 RNA polymerase, which was carried out both with and without the mrGpppG cap structure according to Hemenway et al. (1990) . One lag of linearized DNA produced approximately 5 lag of RNA in reactions containing cap and 10 lag in those without cap as estimated from ethidium bromide-stained 1% agarose gels. The decreased yield of RNA in cap-containing reactions is probably because of the lower concentration of GTP used (300 lai for capped reactions rather than 500 lai for uncapped reactions). All transcript RNAs co-migrated with native CYMV genomic RNA and contained one extra G residue at the 5' end of the RNA after the cap. At the time when the primer was designed, it was believed that two G residues were present at the 5' end of the viral sequence. It has since been shown by direct R N A sequencing that only one is present (Sit et al., 1990) . Transcripts also contain five extra non-viral nucleotides at the 3' terminus as a result of template linearization with XhoI.
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RNA transcripts were tested for infectivity using V. faba as a systemic host. Approximately 4.5 lag of capped or uncapped transcript RNA was added to 8 volumes of inoculation buffer (1% sodium pyrophosphate pH 9, 1% bentonite and 1% Celite; Beck et al., 1990 ) and used to inoculate one leaf of a plant (15 cm high). At 2 weeks post-inoculation, plants inoculated with capped transcripts from clone 10D37 showed symptoms identical to control plants inoculated with an equivalent amount of native CYMV RNA. Symptoms included a yellowgreen mosaic on curled and stunted leaves. Uncapped transcripts originating from either clone 10D37 or 94B18 as well as capped transcripts of clone 94B18 caused no visible symptoms when inoculated into plants. Plants inoculated with linearized plasmid ssDNA or dsDNA from either clone, or with buffer alone, also failed to produce symptoms. Gomphrena globosa, a local lesion host of CYMV, was used to determine the infectivity of transcripts relative to that of native CYMV RNA. Equivalent amounts of transcript R N A and native CYMV RNA (4-5 lag) were used to inoculate opposite leaves of Gornphrena plants. Plant lesion counts (from four independent trials) resulting from transcript RNA were expressed as a percentage of those resulting from native CYMV RNA. Capped transcripts of clone 10D37 were approximately 12% as infectious as wild-type CYMV RNA. Uncapped transcripts of 10D37 as well as capped or uncapped transcripts of 94B18 were not infectious (Table I) .
In order to quantify the virus particles produced from in vitro transcripts, four lesions were isolated from plants inoculated with transcripts from 10D37 and from control plants inoculated with native CYMV RNA. When these were used to inoculate new Gomphrena plants, the infectivity of lesions passaged from in vitro transcripts was similar to that of native CYMV RNA (Table 1) . Restoration of infectivity to the wild-type level may be due to more efficient in vivo capping or to the removal of non-viral sequences. The latter has been shown for many in vitro transcripts of RNA viruses (Ahlquist et al., 1984; Beck et al., 1990; Dawson et al., 1986; Xiong & Lommel, 1991) .
Extracts from these lesions were also stained with 1% uranyl acetate and examined using a Philips 201 transmission electron microscope. Virus particles similar to native purified CYMV were visible in both samples. RNAs extracted from purified virus resulting from systemically infected broad bean plants inoculated with either native CYMV RNA or transcripts from clone 10D37 were analysed by agarose gel electrophoresis. There were no detectable differences between the two RNAs.
The decreased infectivity of capped transcripts of clone 10D37 as compared to native CYMV RNA could have resulted from a number of factors: mutations introduced into the clones by the polymerases used during cDNA synthesis; one extra non-viral nucleotide at the 5' end of the transcripts; incomplete capping of transcripts; an inadequate number of A residues in the poly(A) tail of transcripts or any combination of the above.
Mutations may have resulted in the less efficient infectivity of clone 10D37 and are the most likely cause of the extremely low infectivity of the other full-length clone 94B18. Sequencing of only the 100 nucleotides at the 3' ends of these two clones alone revealed two single base changes between the infectious clone 10D37 and the non-infectious clone 94B18. The G and A residues at positions 6949 and 7014, respectively, in clone 10D37 were changed to A and U residues, respectively, in clone 94B18. Thus, in addition to these two changes in the 3' non-coding region, other differences among these clones may be present elsewhere in the genome, resulting in the lack of infectivity of clone 94B 18.
The presence of more than two extra nucleotides at the 5' ends of transcripts has been shown to decrease or abolish infectivity of viral RNAs markedly (Dawson et al., 1986; van der Werf et al., 1986; Janda et al., 1987; Heaton et al., 1989) . Therefore the extra non-viral G residue of 10D37 may have led to decreased infectivity. The effect of the extra G at the 5' end on the infectivity of CYMV in vitro transcripts is being investigated.
Capping has been shown to increase the efficiency of mRNA translation in vitro and in vivo (Shih et al., 1976; Contreras et al., 1982) as well as mRNA stability (Furuichi et al., 1977; Shimotohno et al., 1977; Green et al., 1983) . The phenomenon of reduced infectivity of uncapped transcripts has been shown for tobacco mosaic virus strain L (Meshi et aL, I986) , WCIMV (Beck et aL, 1990) , cymbidium ringspot virus (Burgyan et al., 1990) and cucumber mosaic virus (Hayes & Buck, 1990) and total loss of infectivity was observed with infectious transcripts of many others. It is not clear whether the cap function is to enhance infectivity by enhancing the translation of viral RNA or by protecting transcripts from degradation.
Native CYMV RNA is known to have a 3' poly(A) tail varying from 75 to 100 residues in length (AbouHaidar, 1983) . The poly(A) tail derived from clone 10D37, however, contained only 23 A residues, possibly resulting in decreased infectivity. Furthermore, mutational studies using infectious transcripts of WC1MV indicated that the reduction of the poly(A) tail from 74 to 10 or to 0 residues decreased infectivity by two-fold and 50-fold, respectively (Guilford et al., 1991) . To determine the importance of the poly(A) tail size for CYMV infectivity, two full-length clones were constructed which contained longer poly(A) tails than clone 10D37. Two smaller cDNA clones, 4A and 20, originating from the 3' region contained poly(A) tails of 80 and 135 A residues, respectively, as determined by sequencing. The 3' end 200 bp MluI/XhoI fragment of clone 10D37 was replaced with the similar fragment from either clone 4A or 20 (Fig. 2b) . This produced full-length clones 374A and 3720, with 80 or 135 A residues in their respective Short communication poly(A) tails. Plasmid DNA of clones 374A and 3720 was linearized with XhoI prior to transcription in the presence of cap. The rate of infectivity was tested on Gomphrena plants by inoculating equivalent amounts of capped transcript RNAs and native CYMV RNAs on opposite leaves (four trials). The infectivity rate of transcripts from clones 374A or 3720 was 17 % and 35 % that of native CYMV RNA, respectively (Table 1) . Thus, by lengthening the size of the poly(A) tail, the infectivity of the transcripts was raised from 12% to 35 % that of native CYMV RNA.
We have described in this communication the construction of a full-length clone of the CYMV genome from two cDNA fragments and have demonstrated the infectivity of in vitro derived transcripts. The infectivity of CYMV transcripts is about 35 % that of native CYMV, which is intermediate between those reported for PVX (0"2 %) (Hemenway et al., 1990) , WCIMV (78 %) (Beck et al., 1990) and PMV (24 %) (Sit & AbouHaidar, 1993) . The effect of the cap and poly(A) tail on the infectivity is similar to that of many other RNA viruses. Clone 3720 will therefore be extremely useful in the future for mutational analyses to determine the functions of the different genes. Specific alterations and gene replacement experiments will allow the study of the replication, symptom development, host range and cisacting elements required for replication and assembly.
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